Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease
- PMID: 19766548
- DOI: 10.1016/j.dld.2009.08.002
Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease
Abstract
Background/aims: To optimize management of nonalcoholic fatty liver disease (NAFLD), a simple screening tool is necessary. In this study, we aimed to devise a simple index of NAFLD.
Study: A cross-sectional study with 10,724 health check-up subjects (5362 cases with NAFLD versus age- and sex-matched controls) was conducted. Study subjects were randomly assigned to a derivation cohort or a validation cohort.
Results: Multivariate analysis indicated that high serum alanine aminotransferase (ALT) to serum aspartate aminotransferase (AST) ratio, high body mass index (BMI), and diabetes mellitus were independent risk factors of NAFLD (all P<0.001). Using these variables, a formula was derived by a logistic regression model: hepatic steatosis index (HSI)= 8 x(ALT/AST ratio)+BMI (+2, if female; +2, if diabetes mellitus). HSI had an area under receiver-operating curve of 0.812 (95% confidence interval, 0.801-0.824). At values of <30.0 or >36.0, HSI ruled out NAFLD with a sensitivity of 93.1%, or detected NAFLD with a specificity of 92.4%, respectively. Of 2692 subjects with HSI <30.0 or >36.0 in the derivation cohort, 2305 (85.6%) were correctly classified. HSI was validated in the subsequent validation cohort.
Conclusion: HSI is a simple, efficient screening tool for NAFLD that may be utilized for selecting individuals for liver ultrasonography and for determining the need for lifestyle modifications.
(c) 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.Gastroenterology. 2006 Jun;130(7):2023-30. doi: 10.1053/j.gastro.2006.03.019. Gastroenterology. 2006. PMID: 16762625
-
Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease.Liver Int. 2006 Mar;26(2):151-6. doi: 10.1111/j.1478-3231.2005.01209.x. Liver Int. 2006. PMID: 16448452
-
Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.Eur J Gastroenterol Hepatol. 2008 May;20(5):399-403. doi: 10.1097/MEG.0b013e3282f448af. Eur J Gastroenterol Hepatol. 2008. PMID: 18403941
-
Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.Eur J Gastroenterol Hepatol. 2010 Jun;22(6):643-50. doi: 10.1097/MEG.0b013e32832ca0cb. Eur J Gastroenterol Hepatol. 2010. PMID: 19478676 Review.
-
Nonalcoholic fatty liver disease.Rev Gastroenterol Disord. 2002;2(1):11-9. Rev Gastroenterol Disord. 2002. PMID: 12122975 Review.
Cited by
-
The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease.Diabetes Metab Syndr Obes. 2024 Oct 19;17:3875-3890. doi: 10.2147/DMSO.S469859. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39444658 Free PMC article.
-
Nigella sativa and Trigonella foenum-graecum Supplemented Chapatis Safely Improve HbA1c, Body Weight, Waist Circumference, Blood Lipids, and Fatty Liver in Overweight and Diabetic Subjects: A Twelve-Week Safety and Efficacy Study.J Med Food. 2020 Sep;23(9):905-919. doi: 10.1089/jmf.2020.0075. Epub 2020 Jul 31. J Med Food. 2020. PMID: 32758056 Free PMC article. Clinical Trial.
-
Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk.Front Immunol. 2022 Sep 23;13:997270. doi: 10.3389/fimmu.2022.997270. eCollection 2022. Front Immunol. 2022. PMID: 36211332 Free PMC article. Review.
-
Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status.JAMA Netw Open. 2023 Dec 1;6(12):e2349856. doi: 10.1001/jamanetworkopen.2023.49856. JAMA Netw Open. 2023. PMID: 38153732 Free PMC article.
-
De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study.Front Med (Lausanne). 2021 Apr 29;8:650818. doi: 10.3389/fmed.2021.650818. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33996858 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources